angiotensin ii has been researched along with salicylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baur, LH; Cats, VM; de Groot, A; Frölich, M; Keirse, MJ; Schipperheyn, JJ; Souverijn, JH; van der Laarse, A; Voogd, PJ; Vroom, TF | 1 |
| Ayyadevera, S; Ding, Z; Goyal, T; Hearnsberger, E; Khaidakov, M; Mehta, JL; Mitra, S; Wang, X | 1 |
1 trial(s) available for angiotensin ii and salicylic acid
| Article | Year |
|---|---|
Combining salicylate and enalapril in patients with coronary artery disease and heart failure.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Coronary Disease; Creatinine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Salicylates; Salicylic Acid | 1995 |
1 other study(ies) available for angiotensin ii and salicylic acid
| Article | Year |
|---|---|
Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
Topics: Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Aspirin; Capillaries; Cells, Cultured; Down-Regulation; Enzyme Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Losartan; Mitogen-Activated Protein Kinases; NADPH Oxidases; Neovascularization, Physiologic; Receptor, Angiotensin, Type 1; RNA, Messenger; Salicylic Acid; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2012 |